<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02604459</url>
  </required_header>
  <id_info>
    <org_study_id>1212915</org_study_id>
    <nct_id>NCT02604459</nct_id>
  </id_info>
  <brief_title>Does Optimized General Anesthesia Care Reduce Postoperative Delirium?</brief_title>
  <acronym>OPCare</acronym>
  <official_title>Does Optimized General Anesthesia Care Reduce Postoperative Delirium In Older Patients Undergoing Hip Fracture Repair?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Missouri-Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Missouri-Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative delirium occurs in up to 65% of elders undergoing surgery for repair of a hip
      fracture and this complication is independently associated with increased morbidity,
      mortality, length of hospital stay, and placement in long-term care institutions. To date,
      the only intervention shown to be effective at minimizing postoperative delirium is a
      proactive geriatric consultation. This prospective randomized clinical trial will randomize
      160 adults, aged 65 years or older, to either optimized general anesthesia or usual general
      anesthesia care for hip fracture surgery to determine if the optimized anesthesia management
      reduces the severity of postoperative delirium.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will be randomized to one of two intraoperative anesthesia treatment groups: 1.)
      Usual care - the anesthetic management will be at the discretion of the anesthesia provider;
      or 1.) Optimal care - the intraoperative depth of anesthesia will be directed using a BIS
      monitor, blood pressure will be maintained within 20% of preoperative levels, and cerebral
      oxygenation will be maintained &gt; 60% during anesthesia. Subjects will be evaluated using the
      Confusion Assessment Method (CAM) for the first 5 postoperative days to determine if they
      experience postoperative delirium.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Severity of postoperative delirium</measure>
    <time_frame>5 postoperative days</time_frame>
    <description>Delirium Rating Scale-Revised-98</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of postoperative delirium</measure>
    <time_frame>5 postoperative days</time_frame>
    <description>Confusion Assessment Method</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perioperative inflammatory response</measure>
    <time_frame>preoperative, day of surgery, and postoperative day 2</time_frame>
    <description>Blood will be drawn for analysis of inflammatory markers including interleukin 6 (IL6), interleukin 10 (IL10), tumor necrosis factor (TNF) alpha on the day prior to surgery, at the end of surgery and on the second postoperative day.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication assessment</measure>
    <time_frame>3 months and 1 year</time_frame>
    <description>The investigators will make a telephone call to the subjects at 3 months and 1 year after surgery to determine if the subject has experienced any complications. We will ask the subjects about the occurrence of infections, strokes, cardiac problems, or respiratory problems since discharge from the hospital.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Hip Fractures</condition>
  <condition>Anesthesia</condition>
  <condition>Delirium</condition>
  <arm_group>
    <arm_group_label>Usual general anesthesia care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will have their general anesthetic management directed at the discretion of the anesthesia provider.
General anesthesia with be maintained with propofol, fentanyl, sevoflurane</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Optimized general anesthesia care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The subjects will have general anesthesia with propofol, fentanyl, sevoflurane. In addition the subjects will be monitored with a depth of anesthesia monitor (BIS) and a cerebral oximeter (Foresight). These additional monitors will be used to direct care. BP management: Systolic BP will be maintained within 20% of baseline systolic BP variables.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>cerebral oximeter (Fore-Sight)</intervention_name>
    <description>The cerebral oximeter will be monitored in the optimized care group and cerebral oxygenation will be maintained at 60% or higher.</description>
    <arm_group_label>Optimized general anesthesia care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>depth of anesthesia monitor (BIS)</intervention_name>
    <description>The depth of anesthesia will be maintained between 40 and 60 in the optimized care group.</description>
    <arm_group_label>Optimized general anesthesia care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>BP management</intervention_name>
    <description>The systolic blood pressure will be maintained within 20% of preoperative levels in the optimized care group.</description>
    <arm_group_label>Optimized general anesthesia care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>General anesthesia</intervention_name>
    <description>General anesthesia will be used in both groups</description>
    <arm_group_label>Usual general anesthesia care</arm_group_label>
    <arm_group_label>Optimized general anesthesia care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <description>propofol per protocol</description>
    <arm_group_label>Usual general anesthesia care</arm_group_label>
    <arm_group_label>Optimized general anesthesia care</arm_group_label>
    <other_name>diprivan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>fentanyl</intervention_name>
    <description>fentanyl per protocol</description>
    <arm_group_label>Usual general anesthesia care</arm_group_label>
    <arm_group_label>Optimized general anesthesia care</arm_group_label>
    <other_name>sublimaze</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sevoflurane</intervention_name>
    <description>maintenance of anesthesia with inhaled sevoflurane</description>
    <arm_group_label>Usual general anesthesia care</arm_group_label>
    <arm_group_label>Optimized general anesthesia care</arm_group_label>
    <other_name>ultane</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject or legal representative has voluntarily signed the informed consent approved
             by the Institutional Review Board,

          -  Hip fracture surgery scheduled under general anesthesia

          -  Subject is 65 years or older on the day of surgery

        Exclusion Criteria:

          -  Inability to follow directions or comprehend the English language

          -  Severe uncorrected visual or auditory handicaps

          -  Delirium at screening or baseline

          -  Emergency surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Terri G Monk, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Missouri-Columbia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Terri G Monk, MD</last_name>
    <phone>5738822568</phone>
    <email>monkt@health.missouri.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Adam Zino, MPh</last_name>
    <phone>57388222568</phone>
    <email>zinoa@health.missouri.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Missouri Hospitals</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terri G Monk, MD</last_name>
      <phone>573-882-2568</phone>
      <email>monkt@health.missouri.edu</email>
    </contact>
    <contact_backup>
      <last_name>Adam Zino, BS, MPH</last_name>
      <phone>5738843740</phone>
      <email>zinoa@health.missouri.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 4, 2015</study_first_submitted>
  <study_first_submitted_qc>November 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2015</study_first_posted>
  <last_update_submitted>May 31, 2017</last_update_submitted>
  <last_update_submitted_qc>May 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Missouri-Columbia</investigator_affiliation>
    <investigator_full_name>Terri Monk</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

